Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model

Yushi Qiu, Zhimin Li, Frederic Pouzoulet, Prakash Vishnu, John A. Copland, Keith L. Knutson, Carole Soussain, Han W. Tun

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)674-678
Number of pages5
JournalBritish journal of haematology
Volume183
Issue number4
DOIs
StatePublished - Nov 2018

Keywords

  • CD274 (PD-L1)
  • PDCD1LG2 (PD-L2)
  • anti-PDCD1 (anti-PD1)
  • primary central nervous system lymphoma (PCNSL)
  • survival

ASJC Scopus subject areas

  • Hematology

Cite this